Erik Renström
Directeur/Membre du Conseil chez Medeon AB
Profil
Erik Renström has worked as a Director at ShoreLink AB since 2019 and is currently employed there.
He also holds a Director position at Medeon AB, where he is currently employed.
Postes actifs de Erik Renström
| Sociétés | Poste | Début |
|---|---|---|
Medeon AB
 Medeon AB Miscellaneous Commercial ServicesCommercial Services Medeon AB is a life science research park located in Malmö, Sweden. The Swedish company offers various services such as incubation, office and conference spaces, and laboratory facilities to its partner companies. Medeon focuses on several areas of research, including diabetes, nanomedicine, and pharma development. The private company has a diverse range of partner companies, including Ascelia Pharma, Biora AB/Straumann, and Gordiamkey. The CEO of the company is Ulf G. Andersson. | Directeur/Membre du Conseil | - |
ShoreLink AB
 ShoreLink AB Other TransportationTransportation ShoreLink AB provides port cargo handling. The private company is based in Pitea, Sweden. The Swedish company was founded in 1928. The CEO is Peter Mörtlund. | Directeur/Membre du Conseil | 01/01/2019 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
ShoreLink AB
ShoreLink AB Other TransportationTransportation ShoreLink AB provides port cargo handling. The private company is based in Pitea, Sweden. The Swedish company was founded in 1928. The CEO is Peter Mörtlund. | Transportation |
Medeon AB
Medeon AB Miscellaneous Commercial ServicesCommercial Services Medeon AB is a life science research park located in Malmö, Sweden. The Swedish company offers various services such as incubation, office and conference spaces, and laboratory facilities to its partner companies. Medeon focuses on several areas of research, including diabetes, nanomedicine, and pharma development. The private company has a diverse range of partner companies, including Ascelia Pharma, Biora AB/Straumann, and Gordiamkey. The CEO of the company is Ulf G. Andersson. | Commercial Services |
